WeihuaWangMD
Pathology • Germantown, TNCytopathology, Anatomic Pathology, Clinical Pathology
Physician
Are you Dr. Wang?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 20 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
7550 Wolf River Blvd
Suite 200
Germantown, TN 38138Phone+1 901-542-6801Fax+1 901-542-6871
Summary
- Dr. Weihua Wang, MD is a board certified pathologist in Germantown, Tennessee. She is currently licensed to practice medicine in Tennessee and Mississippi. She is affiliated with Baptist Memorial Hospital for Women and Baptist Memorial Hospital - Memphis.
Education & Training
Duke University HospitalFellowship, Cytopathology, 2002 - 2003
Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 2001 - 2002
University of TennesseeResidency, Pathology-Anatomic and Clinical, 1997 - 2001
Shanghai Medical UniversityClass of 1982
Certifications & Licensure
MS State Medical License 2005 - 2022
TN State Medical License 2003 - 2022- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Cytopathology
Publications & Presentations
PubMed
- 12 citationsGenomic profiling identifies genes and pathways dysregulated by HEY1-NCOA2 fusion and shines a light on mesenchymal chondrosarcoma tumorigenesis.Wenqing Qi, Wojciech Rosikiewicz, Zhaohong Yin, Beisi Xu, Huihong Jiang
The Journal of Pathology. 2022-08-01 - 2 citationsPancreatoblastomas and mixed and pure acinar cell carcinomas share epigenetic signatures distinct from other neoplasms of the pancreas.Jamal K Benhamida, Monika Vyas, Atsushi Tanaka, Lu Wang, Armita Bahrami
Modern Pathology. 2022-07-01 - 17 citationsRNAseqCNV: analysis of large-scale copy number variations from RNA-seq data.Jan Bařinka, Zunsong Hu, Lu Wang, David A Wheeler, Delaram Rahbarinia
Leukemia. 2022-06-01
Press Mentions
Potential New Target for Early Treatment of Alzheimer's DiseaseJuly 5th, 2024
